about
BMS1 is mutated in aplasia cutis congenitaMutations in KCTD1 cause scalp-ear-nipple syndrome.Age-dependent iris abnormalities in collagen XVIII/endostatin deficient mice with similarities to human pigment dispersion syndrome.Endogenous endostatin inhibits choroidal neovascularization.Age- and gene-dosage-dependent cre-induced abnormalities in the retinal pigment epitheliumClinical genetics of familial keloids.Macrophages are essential for the early wound healing response and the formation of a fibrovascular scar.Doxycycline inhibits polarization of macrophages to the proangiogenic M2-type and subsequent neovascularizationTargeting Platelet-Derived Growth Factor Receptor β(+) Scaffold Formation Inhibits Choroidal Neovascularization.Keloids--clinical diagnosis, pathogenesis, and treatment options.Increased VEGF-A promotes multiple distinct aging diseases of the eye through shared pathomechanisms.Tumor angiogenesis in melanoma.Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels.Genetics of aplasia cutis reveal novel regulators of skin morphogenesis.Collagen XVIII/endostatin is essential for vision and retinal pigment epithelial function.NLRP3 inflammasome blockade inhibits VEGF-A-induced age-related macular degeneration.Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11Leukemic leonine facies: a manifestation of chronic lymphocytic leukemiaClassification of cutaneous intravascular breast cancer metastases based on immunolabeling for blood and lymph vesselsVEGF-A and the NLRP3 Inflammasome in Age-Related Macular Degeneration
P50
Q21092409-173DBC8A-C704-44D4-8F56-3977247220EDQ30448494-AE1D36C4-E689-4309-90DB-1D0DB20FCE05Q31143151-4DC0C258-FD72-4F10-8DDE-CD38B738F549Q33285816-029E6351-F41F-49FA-A46F-F3A3558C0722Q33708713-8641F5EB-A457-478A-B592-BF484A612983Q34101824-2F908D15-25CB-49CD-B6D2-9FE929963ECBQ34679033-723670CF-4133-4B58-A13D-4DD8D4D332FBQ35087983-79BE26F2-753C-44FA-BC48-7F43C52018F9Q36060400-5A5629E5-DD4C-43B0-A06A-0AAFBB69E6E9Q36310772-7015AB2F-CCA7-4DC3-A8B6-BC8CCF5C290EQ36636094-82C9DE2A-54A4-487D-A1DC-88E0E510F73BQ37493343-EB6D13D5-512E-47EB-91A9-34C4AF2B9438Q37702939-8E27F5B6-978F-42F6-8DAD-2863965CFF96Q38263745-8C77BDED-41AC-43C9-8CBF-3FE3965AE7A6Q39315528-E67B690C-9BFA-49E8-9FFA-D51ECA847EC0Q42916834-D708075A-1743-42E8-A634-B4384E128407Q80080197-3259D1CE-96A7-4645-9663-F50398E5D6C2Q81202204-A664236C-CB8C-44C9-892B-AB8BBF020BF8Q83489480-20999869-400F-4986-B490-98480963A08AQ86352092-D920BC83-45A3-4B4C-81A8-0697425EFA7F
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-3866-020X
@en
name
Alexander G Marneros
@ast
Alexander G Marneros
@en
Alexander G Marneros
@es
Alexander G Marneros
@nl
type
label
Alexander G Marneros
@ast
Alexander G Marneros
@en
Alexander G Marneros
@es
Alexander G Marneros
@nl
prefLabel
Alexander G Marneros
@ast
Alexander G Marneros
@en
Alexander G Marneros
@es
Alexander G Marneros
@nl
P106
P1153
7005284852
P31
P496
0000-0003-3866-020X